InterventionsHuman trial

Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia

Blood

The paper

Marlise Rachael Luskin, Julia H. Keating, Benjamin F. Frost,
Show 18 more authorsStella Louise Jaeckle, Shai O. Shimony, Yael Flamand, Jacqueline Suen Garcia, Richard M Stone, Matthew Aaron Booker, Chase Weizer, Jeremy A. Ryan, Jessica Lee, Ilene A Galinsky, Sujal I. Shah, Emma Smith, Arpita Kulkarni, Michael Yevgeniy Tolstorukov, Evan Chris Chen, Eric S. Winer, Anthony Letai, Mark Alan Murakami,
Daniel J. DeAngelo

Dana-Farber Cancer Institute

Blood · 25 Sep 2026

doi.org/10.1182/blood.2026035238PubMed 42789493

More in Interventions